Not known Factual Statements About Oncology products
S. population of sufferers with numerous myeloma. individuals must be randomized to receive a teclistamab-centered program as opposed to straightforward therapy for relapsed or refractory a number of myeloma. The primary endpoint really should be PFS and secondary endpoints ought to contain OS, ORR,